[Normalization of immune function following therapy with Cantastim in a case of chronic T-cell lymphatic leukemia (CTLL)].
Olinescu
A
A
Hristescu
S
S
Sălăgeanu
A
A
Petrovici
A
A
Grigoriu
G
G
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D015461:Leukemia, Prolymphocytic, T-Cell / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D010743:Phospholipids; D011550:Pseudomonas aeruginosa; D013997:Time Factors
D000276:Adjuvants, Immunologic; D010743:Phospholipids; C049675:cantastim
Normalizarea unor funcţii imune consecutiv terapiei cu Cantastim, într-un caz de leucemie limfatică cronică T (LLCT).